AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial
A combination of copanlisib and rituximab led to a 48 percent reduction in the risk…
Browsing: AACR
AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of immune cells
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
AACR 2021: Bispecific fusion protein tebentafusp significantly improves overall survival in patients with metastatic uveal melanoma
Compared with available standard therapies, including immune checkpoint inhibitors, treatment with the bispecific fusion protein…
International cancer breakthroughs on show at AACR 2021
Peter Mac researchers feature in this week’s American Association of Cancer Research program, which is…
AACR 2021: Immunotherapy combination shows early promise in aggressive brain cancers
Immunotherapy together with an experimental cancer drug could offer a new way of treating some…